Pharma Microbiology Congress 2026

20-21 October 2026
Online
English
 
29-30 October 2026
Face-to-face in Milan, Italy
English
 

Conference overview

Become sponsor of Pharma Microbiology Congress 2026, click here

2026 EDITION: NEW FRONTIERS IN STERILE INDUSTRY

The Pharma Microbiology Congress, organized by Pharma Education Center, is recognized as one of the most important and appreciated European conferences dedicated to sterile manufacturing.
This year edition aims to capture a forward looking vision on how sterile manufacturing will evolve over the next years: technological innovation, digitalization, proactive quality management systems, a robust, science based contamination control strategies and, of course, compliance with regulatory expectations will be the main drivers for the next years.
The congress will serve as a meeting point for experts from regulatory agencies, pharmaceutical companies, consultancies, industry associations, and technology providers creating a collaborative environment to shape the future of the sterile manufacturing together.


CONGRESS FORMAT:

📅 VIRTUAL | October 20-21
A dynamic program featuring key presentations on the latest regulatory updates, best practices, and strategies, along with insightful webinars on cutting-edge technologies aimed at improving the manufacturing and control of sterile medicines.

🏛 FACE-TO-FACE DAY 1
October 29 + Networking Aperitivo | NH Milano Congress Center, Italy

We will kick off the face-to-face congress agenda with a session fully dedicated to alternative methods, followed by two interactive workshops led by CRL and Rapid Micro.
In a relaxed and engaging atmosphere, we will welcome you to an exclusive Networking APERITIVO, offering a unique opportunity to connect with industry leaders, colleagues, speakers, and sponsors.

🏛  FACE-TO-FACE DAY 2
October 30 | NH Milano Congress Center, Italy

The in-person program will showcase contributions from leading international speakers, emergent technology representatives, key opinion leaders, and representatives from EU Regulatory Bodies.


This year the congress will include:

12 Thematic Sessions
12 interactives round tables/QA
33 technical speeches
8 webinars on cutting-edge technologies
2 interactives workshops

Road to Pharma Microbiology Congress 2026

ROAD TO PMC 2026 IN PROGRESS

The Pharma Microbiology Congress offers:

  • An interactive format designed to foster knowledge sharing and networking.
  • High-quality scientific content, providing attendees with the opportunity to learn from renowned international SMEs.
  • A platform to share strategies, innovative ideas, and cutting-edge technologies to face the future of sterile manufacturing.
  • The connection with pharmaceutical professionals including key decision-makers at various career levels.

Why attend?

EXPERTS & KOLs OF THE FIELD WILL SHARE THEIR EXPERIENCES AND KNOW HOW:
From regulatory issues to the most technical aspects, our speakers will share their deep expertise with the audience through speeches, round tables and question times: ask questions, rate the ones coming from the audience and let us know what is important for you to know.

STAY UPDATED ON THE LATEST TECHNOLOGIES AND TECHNOLOGICAL ADVANCES
Each day, a session dedicated to new technologies and technological advances that are changing the world of sterile manufacturing. Don’t miss webinars, interviews and demonstrations, and chat with real experts of the field!

Who should attend?

The event is aimed specifically at PharmaBiotech and Medical Device CompaniesRegulatory bodies and Technology Suppliers involved in the manufacturing and control of Sterile medicines.

AGENDA 2026

Find all sessions and their topics in details

OCTOBER 20 | VIRTUAL


SESSION 1 - CCS 2030: THE CORE OF THE MATURE STERILE MANUFACTURING MODE

As the pharmaceutical industry accelerates toward increasingly complex biologics, advanced therapies, and heightened regulatory expectations, the concept of Contamination Control Strategy (CCS) has evolved from a compliance requirement into a foundational pillar of sterile manufacturing excellence. CCS 2030 represents the next stage in this evolution—a fully integrated, risk-based, and data-driven framework that defines the mature sterile manufacturing model of the future. This session sets the stage for understanding how organizations can future-proof sterile manufacturing by embedding CCS at the core of their strategy, transforming compliance into a competitive advantage and ensuring patient safety in an increasingly demanding landscape.

SESSION 2 - ANNEX 1 COMPLIANCE JOURNEY: INDUSTRY CASE STUDIES AND INSIGHTS

This session brings together real-world industry case studies and lessons learned from the Annex 1 compliance journey, offering a pragmatic perspective on how companies are interpreting, implementing, and sustaining the new requirements within their operations. Through diverse examples, speakers will explore how organizations have addressed key areas such as Contamination Control Strategy (CCS )and the integration of Quality Risk Management into daily practices.

SESSION 3 - WEBINARS | DISCOVERING CUTTING-EDGE TECHNOLOGIES (in progress)

This addition to the plenary agenda, much appreciated over the years, is a combination of innovation, expertise and real-time interaction. These webinars offer a unique opportunity to deepen knowledge about innovation as sterile manufacturing moves into a new phase of technology-driven compliance.

SESSION 4 - ENVIRONMENTAL MONITORING: REGULATORY TRENDS AND INNOVATIVE APPROACHES

Environmental Monitoring (EM), a cornerstone of sterile manufacturing assurance, is now recognized as a critical, integrated component of a holistic Contamination Control Strategy (CCS). This session will explore the latest regulatory trends shaping environmental monitoring programs, alongside innovative technologies and approaches redefining how data is collected, analyzed, and utilized. As expectations shift toward risk-based, science-driven, and continuously improving systems, organizations are being challenged to move beyond traditional sampling methods and static limits.

SESSION 5 - TRANSFORMING QUALITY CONTROL THROUGH INNOVATION

The session offers emerging technologies in microbiological control, validation approaches, and technological applications, reflecting on the “microbiological tests of the future.

OCTOBER 21 | VIRTUAL


SESSION 6 - AUTOMATION AND DIGITALIZATION: SHAPING THE FUTURE OF STERILE MANUFACTURING (in progress)

This session will explore how digitalization in sterile manufacturing and laboratory processes is transforming the way operations are designed and managed. By leveraging data-driven approaches and advanced automation, organizations can implement risk-based strategies that enhance decision-making and control. The integration of digital tools enables improved process visibility, consistency, and traceability across the product lifecycle. The session will also feature expert-led discussions of successful case studies, illustrating real-world applications and tangible benefits.

SESSION 7 - CLEANING, DISINFECTION & STERILIZATION: REGULATORY LANDSCAPE & INNOVATION

This session will provide an overview of the current regulatory landscape governing cleaning, disinfection, and sterilization processes. It will examine key regulatory expectations, guidelines, and compliance requirements shaping industry practices. Participants will gain insights into how organizations can align their operations with evolving standards to ensure safety and product quality. The session will also highlight the latest innovations and emerging technologies in this field.

SESSION 8 - WEBINARS | DISCOVERING CUTTING-EDGE TECHNOLOGIES

This addition to the plenary agenda, much appreciated over the years, is a combination of innovation, expertise and real-time interaction. These webinars offer a unique opportunity to deepen knowledge about innovation as sterile manufacturing moves into a new phase of technology-driven compliance.

SESSION 9 - STRENGTHENING STERILITY: REGULATORY TRENDS AND STRATEGIC INNOVATIONS IN RABS & ISOLATORS

This session will explore the latest trends in Restricted Access Barrier Systems (RABS) and isolators within sterile manufacturing. It will address evolving regulatory expectations and how they are shaping the design and operation of these containment systems. Participants will gain insight into industry best practices for ensuring sterility assurance and contamination control. The session will also highlight technological innovations that support critical aspects of these systems, enhancing performance and reliability. Expert contributions will provide practical perspectives on tackling key challenges and advancing containment strategies.

SESSION 10 - PROCESS VALIDATION: BEST PRACTICES, INSIGHTS, AND PERSPECTIVES

This session will present modern validation approaches, focusing on lifecycle management and risk-based strategies. Emphasis will be placed on integrating quality risk management and data integrity into validation frameworks. A key focus will be Aseptic Process Simulation (APS), highlighting best practices in media fill design. Experts will discuss contamination control, environmental monitoring, and APS performance evaluation. Real-world insights and case studies will address common challenges and mitigation strategies.

OCTOBER 29 | MILAN


SESSION 11 - RAPID METHODS: PERSPECTIVES AND APPLICATIONS

This session will provide an international overview of Rapid Microbiological Methods (RMMs) and their growing impact on pharmaceutical quality control and contamination management. A regulatory focus from the Paul Ehrlich Institute (PEI) will explore current expectations, validation strategies, and future regulatory perspectives for the implementation of rapid methods in GMP environments. Through a high-level round table discussion presented by experts involved in Modern Microbiological Methods (M3) initiatives, PDA and representatives from leading pharmaceutical and biotech companies, participants will gain insight into current trends, practical applications, implementation challenges, and future opportunities related to rapid microbiological technologies in the pharmaceutical industry.

SESSION 12 - WORKSHOP at 6.00 PM

Workshop held by Rapid Micro Biosystems

SESSION 13 - WORKSHOP at 6.30 PM

Workshop held by Charles River

NETWORKING APERITIVO

A networking aperitivo will be held in Exhibition Area – NH CONGRESS CENTER from 7.00 pm to 8.30 pm

OCTOBER 30 | MILAN


SESSION 14 - REGULATORS & INDUSTRY: BUILDING THE FUTURE OF STERILE MANUFACTURING

This session will bring together regulatory experts to discuss the evolving landscape of sterile manufacturing. It will explore current and future regulatory expectations, highlighting key trends and areas of focus. Participants will gain valuable insights into how the regulatory framework is shaping industry practices. The session will also emphasize how collaboration between regulators and industry will drive the future of sterile manufacturing.

SESSION 15 - EXCELLENCE IN STERILE PRODUCTION THROUGH INNOVATION

This session will showcase how technological innovation is driving excellence in sterile production. Industry experts will present practical applications in process control and manufacturing environments. The focus will be on advanced solutions that enhance monitoring, consistency, and contamination control.

SESSION 16 - THE EVOLUTION OF STERILE MANUFACTURING

This closing session will feature inspirational talks from leading experts across industry and consulting. Speakers will share their experience, lessons learned, and forward-looking perspectives on sterile manufacturing. The session will highlight key trends shaping the evolution of the sector. It will provide a visionary outlook on how innovation and expertise will define the future of sterile manufacturing.

SPEAKERS 2026 IN PROGRESS


Oleg Krut

Oleg Krut

Head of Microbial Safety Department | Paul Ehrlich Institut (PEI)

Marisa Delbò

Marisa Delbò

Former Head of the Italian GMP Inspectorate and of GMP API Inspection and Manufacturing Authorization Office

Fernanda Ferrazin

Fernanda Ferrazin

Life Sciences Expert, Former GMP Inspector

Adele Romani

Adele Romani

Senior GMP Inspector | AIFA (tbc)

Helena Baião

Helena Baião

Regulatory and Scientific Advice Coordinator | Infarmed

Alan Moon

Alan Moon

Director of AM GMP Limited and former Lead Senior GMDP Inspector at MHRA

Vanessa Vasadi Figueroa

Vanessa Vasadi Figueroa

Founder & Chief Executive Microbiologist | VVF Science

James Drinkwater

James Drinkwater

Franz Ziel GmbH Head of GMP compliance, PHSS Honorary member, ex-Chairman, Annex 1 implementation Focus group leader

Gabriele Gori

Gabriele Gori

PDA Science Advisory Board Past Chair, Global Quality Compliance & Auditing Vice President Global TechOps & Supply | Chiesi Farmaceutici

Francesco Boschi

Francesco Boschi

Microbiology and Aseptic Support – Internal Manufacturing Operational Quality | Pfizer Global Supply

Patrizia Muscas

Patrizia Muscas

Sterility Assurance Director, Global TS.MS | Eli Lilly and Company

Lucia Ceresa

Lucia Ceresa

Freelance Pharmaceutical Consultant – PDA Italy Chapter Board Committee

Allison Scott

Allison Scott

Facilitator at Modern Microbial Method Collaboration, Principal Scientist | BWT Pharma & Biotech Inc and member of MM3

William Dawson

William Dawson

Head of Global manufacturing | Teva

Angela Petrigliano

Angela Petrigliano

CoE Engineering Director | Product Life Italia

Maria Paola Baini

Maria Paola Baini

Global Quality Engineering Front End Lead | Lonza

Andrea Pranti

Andrea Pranti

Qualification Transformation Engineering Manager | GSK Vaccines

Daniele Calzolari

Daniele Calzolari

Italy Risk Management Service Area Manager | Product Life Italia

Martin Pumm

Martin Pumm

Senior Manager, Global Engineering Technology Lead – Fill & Finish | Takeda

Marcia Baroni

Marcia Baroni

VP Quality, Enterprise Systems & Compliance | Emergent BioSolutions, Member Board of Directors |PDA

Mauro Giusti

Mauro Giusti

Executive Director, TSMS Technical Capabilities Training, PDA Italy Chapter Board member, PDA SAB member and PDA PV IG Co-chair | Ely Lilly Italia

Patrizia Ferrari

Patrizia Ferrari

Head of Microbiology Laboratory | Holostem

Simone Penazzi

Simone Penazzi

Senior Pharmaceutical Consulting

Varadharaj Vijayakumar

Varadharaj Vijayakumar

Associate Director – Aseptic Processing Manufacturing operations | Terumo Pharmaceutical Services

Sophie Drinkwater

Sophie Drinkwater

Associate Director, Pharmaceutical Technology & Development | AstraZeneca

Elisabetta Matarrese

Elisabetta Matarrese

Quality Unit Associate Director and Qualified Person | Merck

Guido Fineschi

Guido Fineschi

Qualified Person & Plant Manager | Philogen

Antonio Evangelista

Antonio Evangelista

Manufacturing QA Manager | Fresenius Kabi

Benjamin Daniel

Benjamin Daniel

PHD and Product Manager | MBV

Cécile Delbos

Cécile Delbos

Head of Innovation Digital and Automation, BioMonitoring Life Science – Advanced Solutions | Merck Life Science

Johannes Oberdörfer

Johannes Oberdörfer

Senior Manager Field Application | Rapid Micro Biosystems

Chris Berridge

Chris Berridge

Global Technical consultant, Bio-decontamination specialist | Ecolab

Cristiano Sabelli

Cristiano Sabelli

Scientific and Medical Affairs Director | Copan

Frederic Berkermann

Frederic Berkermann

Commercial Project Lead EMEA, BioMonitoring | Merck Life

David Collins

David Collins

Principal Global Technical Consultant Microbiology | Ecolab

Elena Malpeli

Elena Malpeli

Product & Application Specialist Manager | Copan

Daniele Pandolfi

Daniele Pandolfi

Director of Strategic Marketing & Development | Rigel

Gianluca Sassone

Gianluca Sassone

Sales Manager Process Analytics | Mettler-Toledo

Paola Vigilanza

Paola Vigilanza

PhD and Global Solution Manager Pyrogen Testing | bioMérieux

Guido Cimoli

Guido Cimoli

PhD and Sales Development Manager Automated Solutions | TECAN

Veronika S. Wills

Veronika S. Wills

Director, Global Technical Services | Associates of Cape Cod, Intl, Inc.

SPONSOR 2026 IN PROGRESS

Associates of Cape Cod, Inc.

Silver Sponsor
Associates of Cape Cod, Inc.

Biogenetics Diagnostics

Bronze Sponsor
Biogenetics Diagnostics

BioMérieux

Gold Sponsor
BioMérieux

Bruker

Exhibitor
Bruker

Charles River

Platinum Sponsor
Charles River

Copan

Gold Sponsor
Copan

Ecolab

Silver Sponsor
Ecolab

Euroclone

Exhibitor
Euroclone

LabWorld.it

Media Partner
LabWorld.it

MakingLife

Media Partner
MakingLife

MBV

Bronze Sponsor
MBV

Merck

Silver Sponsor
Merck

Mettler Toledo

Gold Sponsor
Mettler Toledo

Microbiologia Italia

Media Partner
Microbiologia Italia

ProductLife Group/LifeBee

Silver Sponsor
ProductLife Group/LifeBee

Rapid Microbiology

Media Partner
Rapid Microbiology

Rapid Micro Biosystems

Platinum Sponsor
Rapid Micro Biosystems

RIGEL

Gold
RIGEL

Steriline

Exhibitor
Steriline

Become a sponsor

The Pharma Microbiology Congress 2026 provides an excellent opportunity to get in touch with microbiology/sterility assurance professionals and decision makers. To sponsor the event, contact us!

Check out our sponsorship opportunities here: Become PMC Sponsor

Conference Venue

The Pharma Microbiology Congress 2026 will be a mixed event:

Step 1
On October 20-21 the event will be VIRTUAL to grant you the possibility of joining the conference even from your office or home, wherever you may be.
We have organized a true virtual location, a space where you will be able to:

  • Follow the live streaming of the congress, listen to experts and opinion makers and be informed about latest trends and technological breakthroughs in sterile manufacturing
  • Visit the VIRTUAL EXHIBITION AREA and all the stands of our sponsors
  • Join Q&A times and round tables to discuss the current hot topics in the field
  • Chat with our sponsors and learn about new technologies and services to ease your daily work and increase the performance

Step 2

COCKTAIL DINNER
Reserve your place to meet and network with your colleagues, experts and opinion leaders!
Let’s finally meet face to face in Milan on October 29-30! A great chance to meet in person the PMC experts and colleagues. The conference will be hosted in the wonderful spaces of NH Milano Congress Centre, in Assago, Milan.

By plane

From Malpensa Airport:

    • take the bus to the central station, then the subway towards Assago Milanofiori Forum
    • take the express train from Malpensa to the Cadorna station, then the Green subway in the direction of Assago Milanofiori Forum.

From Linate Airport:
take the bus to San Babila station, then the subway towards Assago Milanofiori Forum.

By train

From Centrale or Cadorna train station, take green line subway to Assago Milanofiori Forum.

By tram

From Piazza del Duomo:
take the red subway line towards RHO FIERAMILANO and change at CADORNA. Take the green line towards ASSAGO MILANOFIORI FORUM and get off at the Assago Milanofiori Forum stop. Walk for about 7 minutes to reach the hotel.

All the past editions

Download brochures from previous editions of Pharma Microbiology Congress 2026

Sign up for the conference

Face to Face (29-30/10/26)
Early bird until 21/09/2026*

400€
480€

Virtual (20-21/10/26)
Early bird until 21/09/2026*

700€
800€

Virtual + Face to Face (20-21/10/26 and 29-30/10/26)
Early bird until 21/09/2026*

930€
1080€

Attendance to the event will be allowed upon receipt of payment.

* Hospitals, Universities and freelancers get a 40% discount on published prices (discounts cannot be combined).

- +

Ask for information

Ask for information

Subscribe to our newsletter!

Get 15% off any course of your choice.